AZUR Pharma, the pharmaceutical company set up by former Elan executive Seamus Mulligan, has successfully completed a private placement of ordinary shares, raising $48 million (€35 million).

AZUR Pharma, the Dublin company set up by former Elan executive Seamus Mulligan, has acquire the schizophrenic treatment FazaClo.